The Managed Care Injectables Index
Produced twice a year, the Injectables Index offers the largest and most detailed analysis of managed care’s approach to injectable therapies. The tenth edition of this landmark study was released in Fall 2007. The Injectables Index provides a rich and informative understanding of the most important key trends, including:
- Trends in formulary management and benefit design, including ASP adoption
- Patient cost-sharing levels and trends
- Current commercial reimbursement rates, in different settings
- Trends in patient self-administration
- Category management trends and other management strategies
- The use of specialty pharmacy vendors
Click on the slide below to see highlights from the 2007 Fall issue:
You can read more about the Managed Care Injectables Index in Biotechnology Healthcare’s October 2006 issue.
For a product prospectus, or if you would like more information, contact us at strategy@zitter.com.